Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
Severe weather warning in your area. Please stay indoors and stay safe. Read more
regimen
AALL1131(CONS)
- Cancer Type
- Hematologic, Leukemia - Acute Lymphoblastic (ALL)
- Regimen Category
-
evidence-informed
- Funding Program
-
ODB - General Benefit mercaptopurine New Drug Funding Program Calaspargase Pegol (Outpatient) - Newly Diagnosed Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia
- Drugs Used
- methotrexate , cyclophosphamide , cytarabine , mercaptopurine , pegaspargase , vinCRIStine
Regimen Monograph
Nov 2024
Patient Info Sheet
Please see Drugs Used for related Patient Information Sheets. Patient Information Sheets are not yet available for this regimen.
Last Updated: July 27, 2026
